157 related articles for article (PubMed ID: 32276937)
1. Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea.
Youn SH; Kim YJ; Seo SS; Kang S; Lim MC; Chang HK; Park SY; Kim JY
Int J Gynecol Cancer; 2020 Jun; 30(6):764-771. PubMed ID: 32276937
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
3. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
4. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy.
Kim H; Cho WK; Kim YJ; Kim YS; Park W
Gynecol Oncol; 2020 May; 157(2):423-428. PubMed ID: 32139148
[TBL] [Abstract][Full Text] [Related]
5. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
7. Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
Jouglar E; Thomas L; de la Rochefordière A; Noël G; Le Blanc-Onfroy M; Delpon G; Campion L; Mahé MA
Cancer Radiother; 2016 Dec; 20(8):794-800. PubMed ID: 28270323
[TBL] [Abstract][Full Text] [Related]
8. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes of MRI Stage IIB Cervical Cancer.
Yoon A; Park JJ; Park BK; Lee YY; Paik ES; Choi CH; Kim TJ; Kim CK; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2016 Sep; 26(7):1252-7. PubMed ID: 27284726
[TBL] [Abstract][Full Text] [Related]
10. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
11. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
14. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
Kim JY; Kim JY; Kim JH; Yoon MS; Kim J; Kim YS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):741-7. PubMed ID: 22898382
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
Lee J; Kim TH; Kim GE; Keum KC; Kim YB
J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.
Onal C; Yildirim BA; Guler OC; Mertsoylu H
Int J Gynecol Cancer; 2018 Oct; 28(8):1553-1559. PubMed ID: 30247248
[TBL] [Abstract][Full Text] [Related]
18. Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging.
Choi YS; Yi CM; Sin JI; Ye GW; Shin IH; Lee TS
Int J Gynecol Cancer; 2006; 16(5):1846-54. PubMed ID: 17009981
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
[TBL] [Abstract][Full Text] [Related]
20. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
